Value and significance of brain radiation therapy during first‐line EGFR‐TKI treatment in lung adenocarcinoma with EGFR sensitive mutation and synchronous brain metastasis: Appropriate timing and technique

BACKGROUND: For lung adenocarcinoma patients with epidermal growth factor receptor (EGFR) sensitive mutation and synchronous brain metastasis (syn‐BM), when and how to apply radiotherapy (RT) during first‐line tyrosine kinase inhibitor (TKI) treatment remains debatable. METHODS: From a real‐world mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yangchun, Xu, Yan, Zhuang, Hongqing, Jiang, Weijuan, Zhang, Hua, Li, Xiaofeng, Liu, Yonggang, Ma, Li, Zhao, Dahai, Cheng, Yuan, Yu, Yan, Liu, Ping, Qin, Jianwen, Chen, Xueqin, Gao, Junzhen, Wang, Mengzhao, Liang, Li, Cao, Baoshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636222/
https://www.ncbi.nlm.nih.gov/pubmed/34651449
http://dx.doi.org/10.1111/1759-7714.14169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636222/
https://www.ncbi.nlm.nih.gov/pubmed/34651449
http://dx.doi.org/10.1111/1759-7714.14169

Ejemplares similares